United Medicine is a company specializing in the research, development, production and sales of molecular diagnostic products. The company is engaged in the early screening of tumors and infectious diseases and individualized medical research, and is committed to individualized diagnosis and treatment platforms for tumors, cardiovascular and cerebrovascular diseases and other major diseases, providing scientific guarantee for early clinical diagnosis, drug selection, efficacy monitoring and prognosis judgment. Recently, United Medicine received a new round of financing of 20 million yuan. The investor is Liedman, accounting for 3.5088%. The post-investment valuation is RMB 570 million.
This article is reproduced from: https://www.itjuzi.com/investevent/13654685
This site is for inclusion only, and the copyright belongs to the original author.